Skip to main content

Table 7 Costs and QALY of the quadrivalent and nonavalent vaccination strategies

From: Estimating the cost-effectiveness profile of a universal vaccination programme with a nine-valent HPV vaccine in Austria

 

4-valent vaccination

9-valent vaccination

Difference

Costs/person (€)a

288.44

297.18

8.74

QALYs/personb

26.81176

26.81229

0.00053

Cost/QALY (€/QALY)

–

–

16.441

  1. aCosts rounded to 0.01
  2. bQALY rounded to 0.00001
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us